Brigatinib is another treatment option for patients diagnosed with advanced ALK-positive non-small-cell lung cancer who are treatment-naïve or who have progressed on or are intolerant to crizotinib

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Curr Oncol
Main Authors: Melosky, Barbara, Cheema, Parneet, Liu, Geoffrey
Formáid: Artigo
Teanga:Inglês
Foilsithe: Multimed Inc. 2019
Ábhair:
Letter to the Editor
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6380641/
https://ncbi.nlm.nih.gov/pubmed/30853819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4809
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla